Subject: mail text to Mylan
From: Maia Nikoleishvili <[email-masked]>
To: akaki abutidze <[email-masked]>
Date: Sun, 25 Oct 2020 10:18:06 +0000

Dear Mr. Abhishek and Mr. Suresh,

I would like to kindly address you from the Infectious Diseases, AIDS and Clinical Immunology Research Cente of Georgia.

Please be informed that the provided draft letter of Agreement does not cover the required provisions necessary to formalize contractual relations between our parties. Therefore, I would like to share with you our draft procurement agreement for your revision. Please kindly send your comments/suggestions ASAP.

As for the import license, please note that according to the sub-paragraph „a“ of the Article 1113 of Georgian Law on “Medicines and Pharmaceutical Activities”, pharmaceutical product may be imported circumventing the regimes for granting marketing authorisation in Georgia for non-commercial purposes in case of pre-clinical and clinical trials. The medicine “Remdesivire” will be used within the “Solidarity Trial” and consequently, import license is not required.

Hereby, please be informed that in the attached draft Agreement is mentioned that the procured medication will be used only for non-commercial purposes by the medical facilities involved in the trial. However, if you still require the confirmation letter, the AIDS Center will proceed.

Looking forward to receiving your feedback.

Thank you for continued cooperation and support.